MAPK8 and Alzheimer disease: We previously demonstrated in the CRND8 AD mouse model that Aβ oligomers powerfully trigger JNK activation before PSD alteration [3,10,11,13], and we proved the key role of JNK by using D-JNKI1, a cell-permeable peptide that inhibits all JNK isoforms.